Ratings by Alliance Global Partners (James Molloy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/30/2023 | Alimera Sciences | ALIM | Upgrade | Buy (Neutral) |
3.16 (3.31) |
4.75% | Details | |
| 10/9/2023 | Aptevo Therapeutics | APVO | New Coverage | Buy (N/A) |
0.33 (0.68) |
106.06% | Details | |
| 10/2/2023 | AcelRx Pharmaceuticals | ACRX | New Coverage | Buy (N/A) |
0.58 (0.86) |
48.28% | Details | |
| 9/25/2023 | Vaccitech | VACC | New Coverage | Buy (N/A) |
1.68 (5.00) |
197.62% | Details | |
| 7/17/2023 | NeuroSense Therapeutics Ltd. | NRSN | New Coverage | Buy (N/A) |
1.36 (1.26) |
-7.35% | Details | |
| 6/12/2023 | Alimera Sciences | ALIM | Upgrade | Buy (Neutral) |
2.50 (3.31) |
32.4% | Details | |
| 3/6/2023 | Athersys | ATHX | New Coverage | Buy (N/A) |
1.53 (0.10) |
-93.46% | Details | |
| 1/23/2023 | Hepion Pharma | HEPA | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Alimera Sciences | ALIM | Downgrade | Neutral (Buy) |
4.25 (3.31) |
-22.12% | Details | |
| 6/1/2022 | Enveric Biosciences | ENVB | New Coverage | Buy (N/A) |
0.20 (0.90) |
350% | Details | |
| 3/24/2022 | Ampio Pharmaceuticals | AMPE | New Coverage | Buy (N/A) |
0.43 (0.35) |
-18.6% | Details | |
| 3/16/2022 | Entasis Therapeutics | ETTX | Downgrade | Neutral (Buy) |
1.86 (2.19) |
17.74% | Details | |
| 11/9/2021 | Oramed Pharma | ORMP | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
8.45 (4.58) |
-45.8% | Details | |
| 4/5/2021 | Ocuphire | OCUP | New Coverage | Buy (N/A) |
6.38 (1.54) |
-75.86% | Details | |
| 11/16/2020 | Entasis Therapeutics | ETTX | New Coverage | Buy (N/A) |
1.72 (2.19) |
27.33% | Details | |
| 8/25/2020 | Qualigen Therapeutics | QLGN | Upgrade | Buy (Neutral) |
4.62 (0.30) |
-93.51% | Details | |
| 8/10/2020 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
14.21 (4.81) |
-66.15% | Details | |
| 5/5/2020 | Stemline Therapeutics | STML | Downgrade | Neutral (Buy) |
4.75 (11.83) |
149.05% | Details | |
| 4/22/2020 | Genprex | GNPX | New Coverage | Buy (N/A) |
1.99 (2.12) |
6.53% | Details | |
| 2/28/2020 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | AIM ImmunoTech | AIM | New Coverage | Buy (N/A) |
0.49 (0.41) |
-16.33% | Details | |
| 11/26/2019 | Tonix Pharma | TNXP | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2019 | Stemline Therapeutics | STML | New Coverage | Buy (N/A) |
10.61 (4.75) |
-55.23% | Details | |
| 11/14/2019 | COCP | Maintain | Buy (N/A) |
|
Details | |||
| 5/17/2019 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details |
